So do you agree that the benefit is more than rounding with respect to the overall purchase price? No. The value of ARIA will be dominated by the drugs, patents,cash, cash burn, litigation risk/costs. The value of tax losses to the buyer will be lost in the other factors, a buyout - IF - IF one happens will not be about the tax advantages of ARIA. No company is going to buy ARIA for the tax losses.